Treatment of Neurasthenia (weakness in nerves) with Unani medicine Majoon-e-Lana
Phase 3
- Conditions
- Health Condition 1: F488- Other specified nonpsychotic mental disorders
- Registration Number
- CTRI/2023/09/057339
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either gender in the age group of 18-60 years
2. Patients having ?u‘f A‘? ?b(Neurasthenia) as per the diagnostic criteria
Exclusion Criteria
1. Patients below the age of 18 and above the age of 60 years
2. Patients having any systemic disease, chronic debilitating disease, T.B., Diabetes Mellitus etc.
3. History of any kind of addiction (Alcohol, Drugs and etc.)
4. Known case of Carpal tunnel syndrome, herniated disc syndrome, peripheral nerve injury.
5. Known cases of Any Neuromuscular abnormalities,neuromuscular junction disorders, Myasthenia gravis, Muscular disorders, Diabetic neuropathy, Autonomic neuropathies
6. Pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of trial drug will be assessed on the basis of Clinical Global Impression (CGI) improvement of severity scale and the Visual Analogues Scales for the sense of fatigue and well-being.Timepoint: At every 2 weeks for 6 weeks
- Secondary Outcome Measures
Name Time Method Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline, 2nd week & at 6th week.